A detailed history of Cwm, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cwm, LLC holds 314 shares of RGEN stock, worth $43,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314
Previous 361 13.02%
Holding current value
$43,938
Previous $66,000 39.39%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$120.0 - $182.95 $5,640 - $8,598
-47 Reduced 13.02%
314 $40,000
Q1 2024

Apr 05, 2024

BUY
$170.78 - $208.42 $10,246 - $12,505
60 Added 19.93%
361 $66,000
Q4 2023

Feb 01, 2024

SELL
$114.17 - $185.35 $10,389 - $16,866
-91 Reduced 23.21%
301 $54,000
Q3 2023

Oct 11, 2023

BUY
$138.78 - $176.51 $1,110 - $1,412
8 Added 2.08%
392 $62,000
Q2 2023

Aug 03, 2023

BUY
$138.42 - $180.31 $8,582 - $11,179
62 Added 19.25%
384 $54,000
Q1 2023

Apr 28, 2023

SELL
$154.26 - $198.1 $8,484 - $10,895
-55 Reduced 14.59%
322 $54,000
Q3 2022

Oct 27, 2022

BUY
$160.42 - $256.21 $37,377 - $59,696
233 Added 161.81%
377 $71,000
Q2 2022

Jul 28, 2022

BUY
$140.68 - $188.02 $7,737 - $10,341
55 Added 61.8%
144 $23,000
Q1 2022

Apr 21, 2022

BUY
$161.19 - $257.96 $10,154 - $16,251
63 Added 242.31%
89 $17,000
Q4 2021

Jan 31, 2022

BUY
$247.59 - $304.47 $2,723 - $3,349
11 Added 73.33%
26 $7,000
Q1 2021

Sep 15, 2021

SELL
$180.37 - $226.26 $3,968 - $4,977
-22 Reduced 59.46%
15 $3,000
Q1 2021

Apr 27, 2021

BUY
$180.37 - $226.26 $3,968 - $4,977
22 Added 146.67%
37 $7,000
Q4 2020

Sep 15, 2021

SELL
$148.08 - $206.57 $3,257 - $4,544
-22 Reduced 59.46%
15 $3,000
Q4 2020

Jan 27, 2021

BUY
$148.08 - $206.57 $3,257 - $4,544
22 Added 146.67%
37 $7,000
Q2 2020

Sep 15, 2021

BUY
$94.33 - $140.48 $1,414 - $2,107
15 New
15 $3,000
Q2 2020

Jul 22, 2020

SELL
$94.33 - $140.48 $1,414 - $2,107
-15 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$84.96 - $109.14 $1,274 - $1,637
15 New
15 $3,000
Q1 2020

Apr 28, 2020

SELL
$84.96 - $109.14 $1,274 - $1,637
-15 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$73.84 - $93.08 $1,107 - $1,396
15 New
15 $3,000
Q4 2019

Jan 27, 2020

SELL
$73.84 - $93.08 $1,107 - $1,396
-15 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$76.65 - $95.51 $1,149 - $1,432
15 New
15 $3,000
Q3 2019

Oct 22, 2019

SELL
$76.65 - $95.51 $1,149 - $1,432
-15 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$54.2 - $85.95 $813 - $1,289
15 New
15 $3,000
Q2 2019

Jul 31, 2019

SELL
$54.2 - $85.95 $813 - $1,289
-15 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$49.45 - $62.8 $741 - $942
15 New
15 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.76B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.